Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
17.27 Down 0.07(0.40%) 4:00PM EST
|After Hours : 17.28 Up 0.01 (0.03%) 4:32PM EST
Add to Portfolio
Prev Close:17.34
Open:17.31
Bid:14.50 x 300
Ask:17.79 x 400
1y Target Est:22.50
Beta:0.05
Next Earnings Date: 5-Mar-15OSIR Earnings announcement
Day's Range:17.18 - 17.39
52wk Range:11.80 - 17.69
Volume:78,366
Avg Vol (3m):115,513
Market Cap:592.71M
P/E (ttm):12.51
EPS (ttm):1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRDown 0.40%592.71M
ABTDown 0.50%71.33B
BIIBDown 0.12%96.10B

Key Statistics

Forward P/E (1 yr):52.33
P/S (ttm):12.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.02
Quarterly EPS Est (Dec-14) :0.05
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing products to treat medical conditions in wound care, orthopedic, and sports medicine markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback